Biogen Inc. (BIIB) · 38 Years of Financial statements

Income Statement

Revenue

15

6

9

21

29

50

61

124

136

156

152

277

434

558

794

926

1,043

1,148

679

1,596

1,714

1,872

3,172

4,098

4,377

4,716

5,049

5,516

6,932

9,703

10,764

11,449

12,274

13,453

14,378

13,445

10,982

10,173

COGS

5

23

21

25

35

43

2

6

10

11

29

50

75

111

125

137

160

285

554

374

274

335

402

382

400

467

545

858

1,171

1,240

1,479

1,630

1,816

1,955

1,805

2,110

2,278

Gross Profit

11

(17)

(12)

(1)

3

15

18

122

131

146

141

249

384

483

683

801

907

988

394

1,042

1,340

1,598

2,836

3,696

3,995

4,316

4,582

4,971

6,074

8,532

9,523

9,970

10,644

11,637

12,423

11,639

8,872

7,895

Gross Profit Ratio

70.20%

(264.06)%

(144.19)%

(2.43)%

11.58%

29.34%

29.48%

98.22%

95.97%

93.64%

93.08%

89.71%

88.44%

86.64%

86.03%

86.49%

86.92%

86.05%

58.08%

65.26%

78.20%

85.34%

89.43%

90.19%

91.27%

91.51%

90.75%

90.11%

87.63%

87.93%

88.48%

87.08%

86.72%

86.50%

86.40%

86.57%

80.79%

77.61%

Operating Expenses

44

12

11

12

14

19

93

109

148

134

208

235

292

367

473

547

692

1,264

1,614

1,695

1,991

1,973

2,457

2,700

2,747

2,838

3,132

3,584

4,616

4,509

4,317

5,116

5,636

5,387

7,193

6,064

4,635

R&D Expenses

- -

91

87

132

146

177

221

303

315

368

1,056

688

748

1,049

925

1,072

1,283

1,249

1,220

1,335

1,444

1,893

2,013

1,973

2,254

2,597

2,281

3,991

2,501

2,231

Selling, G&A Exp.

39

8

9

10

14

86

103

25

40

74

90

115

146

170

232

324

175

578

645

685

776

925

1,127

1,290

1,374

1,277

1,712

2,232

2,113

1,948

1,936

2,106

2,375

2,505

2,674

2,404

General and Admin. Exp.

- -

Selling and Marketing Exp.

- -

Other Expenses

5

4

3

4

5

7

32

6

2

(1)

- -

33

348

302

257

272

460

290

209

245

520

428

490

383

396

927

932

732

698

889

- -

COGS and Expenses

48

36

33

38

49

63

95

115

158

144

236

285

367

478

598

683

852

1,549

2,168

2,068

2,266

2,308

2,859

3,082

3,147

3,305

3,678

4,442

5,787

5,749

5,796

6,746

7,452

7,342

8,998

8,174

6,913

Interest Income

- -

41

34

57

63

101

104

72

49

22

19

30

8

12

22

63

79

113

120

42

11

- -

Interest Expense

- -

4

15

19

10

1

41

52

36

33

37

32

30

96

260

251

201

187

223

254

- -

Depreciation and Amortization

5

4

3

(3)

(4)

(5)

(7)

8

11

15

19

25

31

39

37

45

61

439

402

376

380

462

428

354

359

366

532

688

600

683

1,081

1,017

681

457

488

518

EBITDA

(14)

(24)

(19)

2

0

4

2

33

28

6

18

56

168

235

360

526

426

325

(804)

522

668

873

1,331

1,663

1,790

1,727

2,071

2,253

3,027

4,642

5,405

5,883

6,330

7,074

7,915

5,673

2,350

4,198

EBITDA ratio

(94.04)%

(370.31)%

(216.28)%

10.68%

0.35%

8.38%

3.91%

26.52%

20.45%

3.93%

12.10%

20.24%

38.77%

42.11%

45.33%

56.77%

40.87%

28.32%

(118.40)%

32.74%

38.98%

46.61%

41.98%

40.59%

40.88%

36.61%

41.02%

40.84%

43.67%

47.84%

50.21%

51.38%

51.57%

52.58%

55.05%

42.19%

21.40%

41.27%

Operating Income

(33)

(29)

(24)

(12)

(9)

1

(1)

29

22

(2)

7

41

149

191

316

328

360

297

(870)

43

236

440

780

1,214

1,295

1,249

1,725

1,856

2,516

3,972

4,891

5,150

5,344

5,889

7,043

4,550

2,841

3,260

Operating Income ratio

(217.88)%

(454.69)%

(281.40)%

(57.77)%

(31.58)%

1.60%

(2.12)%

23.12%

15.91%

(1.22)%

4.91%

14.73%

34.32%

34.19%

39.81%

35.44%

34.52%

25.83%

(128.05)%

2.72%

13.77%

23.50%

24.59%

29.62%

29.59%

26.48%

34.16%

33.64%

36.29%

40.94%

45.44%

44.99%

43.54%

43.77%

48.98%

33.84%

25.87%

32.05%

Total Other Income Exp.(Gains)

14

1

2

11

12

7

9

11

13

- -

20

13

159

29

(20)

(11)

21

20

52

131

(65)

37

(19)

(13)

(1)

(35)

(26)

(124)

(217)

(215)

11

83

497

(1,096)

331

Income Before Tax

(19)

(28)

(22)

(1)

3

8

40

35

(2)

7

41

149

210

329

487

389

277

(881)

64

256

492

911

1,149

1,333

1,230

1,711

1,855

2,481

3,947

4,767

4,933

5,129

5,900

7,126

5,048

1,745

3,592

Income Before Tax ratio

(123.84)%

(434.38)%

(260.47)%

(4.37)%

11.93%

15.97%

12.21%

32.26%

25.37%

(1.22)%

4.91%

14.73%

34.32%

37.70%

41.42%

52.58%

37.33%

24.09%

(129.66)%

4.02%

14.95%

26.29%

28.71%

28.04%

30.44%

26.08%

33.89%

33.63%

35.78%

40.67%

44.29%

43.09%

41.79%

43.85%

49.56%

37.54%

15.89%

35.31%

Income Tax Expense (Gain)

0

2

3

2

0

60

71

109

154

117

77

(6)

39

95

278

272

366

356

331

445

471

601

990

1,162

1,237

2,459

1,426

1,158

992

53

633

Net Income

(19)

(28)

(23)

(1)

3

8

7

38

32

(5)

6

41

89

139

220

334

273

199

(875)

25

161

218

638

783

970

1,005

1,234

1,380

1,862

2,935

3,547

3,703

2,539

4,431

5,889

4,001

1,556

3,047

Net Income Ratio

(126.49)%

(440.63)%

(262.79)%

(5.83)%

11.23%

15.37%

11.73%

30.96%

23.75%

(3.13)%

3.73%

14.63%

20.54%

24.87%

27.75%

36.01%

26.14%

17.34%

(128.85)%

1.57%

9.38%

11.62%

20.12%

19.11%

22.16%

21.31%

24.45%

25.02%

26.87%

30.25%

32.95%

32.34%

20.69%

32.93%

40.96%

29.76%

14.17%

29.95%

EPS

(0.04)

(0.06)

(0.04)

(0.00)

0.00

0.01

0.05

0.04

(0.03)

0.03

0.09

0.20

0.31

0.49

0.75

1.84

1.33

(4.92)

0.07

0.48

0.64

2.02

2.67

3.37

3.98

5.09

5.80

7.86

12.42

15.38

16.96

11.94

21.63

31.47

24.86

10.44

20.44

EPS Diluted

(0.04)

(0.06)

(0.04)

(0.00)

0.00

0.01

0.04

(0.03)

0.03

0.09

0.20

0.30

0.47

0.72

1.78

1.31

(4.92)

0.07

0.47

0.63

1.99

2.65

3.35

3.94

5.04

5.76

7.81

12.37

15.34

16.93

11.92

21.58

31.42

24.80

10.40

20.37

Weighted Avg. Shares Outs.

441

470

522

360

120

540

675

821

748

197

219

439

443

450

446

148

149

178

335

336

339

316

292

287

252

242

238

237

236

231

218

213

205

187

161

149

Weighted Avg. Shares Outs. Dil.

441

470

522

360

120

540

675

851

810

197

705

923

459

463

473

464

153

152

178

343

346

345

320

295

289

255

245

240

238

237

231

219

213

205

187

161

150

SEC Link

Link

Balance Sheet

Cash and Cash Equivalents

54

71

54

33

13

57

86

75

55

46

62

70

25

57

49

54

45

315

209

568

661

660

622

582

760

515

571

603

1,205

1,308

2,327

1,574

1,225

2,914

1,331

2,261

3,419

Short-Term Investments

- -

213

262

259

370

491

598

634

744

822

521

- -

241

319

749

682

448

1,176

1,135

620

640

2,121

2,569

2,115

2,313

1,562

1,279

1,541

1,474

Cash & Short-Term Investments

54

71

54

33

13

57

86

75

268

308

321

440

517

655

682

798

867

836

209

568

903

979

1,371

1,264

1,208

1,691

1,706

1,223

1,845

3,429

4,895

3,689

3,538

4,476

2,610

3,803

4,893

Net Receivables

2

3

2

6

13

18

33

32

19

20

43

87

101

137

143

178

171

316

416

407

486

559

654

745

840

813

955

1,077

1,576

1,542

1,742

2,320

2,485

2,471

2,327

1,962

1,705

Inventory

- -

95

496

251

183

169

234

264

294

289

327

447

659

804

893

1,002

903

930

804

1,069

1,352

1,344

Other Current Assets

1

2

81

95

134

149

203

8

13

71

69

76

118

103

122

82

190

1,054

460

155

596

169

178

204

145

136

226

447

837

1,093

962

688

631

881

741

1,849

Total Current Assets

57

74

58

120

121

209

268

309

295

340

436

596

694

910

928

1,098

1,216

1,839

1,931

1,618

1,713

2,368

2,458

2,481

2,540

2,975

3,244

3,185

4,673

6,700

8,732

7,873

7,641

8,382

6,887

7,857

9,791

PP&E

21

19

14

15

24

29

32

39

73

115

165

174

183

240

400

556

738

1,253

1,525

1,174

1,280

1,497

1,595

1,637

1,642

1,571

1,742

1,751

1,766

2,188

2,502

3,182

3,601

3,674

3,845

3,792

3,703

Goodwill

- -

1,151

1,130

1,155

1,137

1,139

1,146

1,201

1,233

1,760

2,664

3,669

4,633

5,706

5,758

5,762

5,761

5,749

Intangible Assets

2

3

4

5

6

7

8

10

15

16

14

17

16

3,639

3,293

2,976

2,747

2,492

2,161

1,871

1,773

1,608

1,632

4,475

4,029

4,085

3,808

3,880

3,120

3,527

3,084

2,221

1,850

Goodwill and Intangible Assets

2

3

4

5

6

7

8

10

15

16

14

17

16

4,790

4,444

4,106

3,902

3,630

3,300

3,010

2,919

2,755

2,833

5,708

5,789

6,749

7,478

8,512

8,826

9,285

8,846

7,982

7,599

Investments

- -

4

1,623

156

264

1,658

1,133

1,127

1,424

991

1,748

2,311

1,220

2,089

3,868

4,165

4,085

3,067

2,661

3,671

2,832

706

Tax Assets

- -

2,154

3,232

1,370

1,415

1,226

Other Non-Current Assets

5

6

5

6

8

4

2

6

23

28

32

114

90

51

33

- -

1,110

1,204

- -

1,529

Total Non-Current Assets

29

27

23

26

38

44

43

48

83

129

199

218

231

368

504

623

791

7,665

7,235

6,749

6,840

6,260

6,021

6,071

5,552

6,074

6,886

8,678

9,644

12,805

14,145

15,779

17,648

18,853

17,732

16,021

14,763

Other Assets

- -

0

- -

Total Assets

86

101

81

145

159

253

311

357

378

469

635

814

925

1,278

1,432

1,721

2,007

9,504

9,166

8,367

8,553

8,629

8,479

8,552

8,092

9,050

10,130

11,863

14,317

19,505

22,877

23,653

25,289

27,234

24,619

23,877

24,554

Accounts Payable

- -

2

3

4

3

10

13

16

25

30

38

51

65

63

121

100

91

107

119

163

186

204

220

229

267

280

396

371

531

455

589

492

Short-Term Debt

- -

2

4

30

5

- -

748

- -

1,511

28

20

137

3

453

4

3

5

3

- -

1,496

- -

999

- -

Tax Payable

- -

74

94

129

200

146

11

223

76

85

46

20

180

168

209

232

68

64

71

142

175

260

Deferred Revenue

- -

7

14

17

- -

41

- -

148

173

121

56

- -

Other Current Liabilities

7

8

4

10

11

22

29

38

39

68

78

105

155

178

239

183

240

248

266

337

576

565

501

625

677

832

1,183

1,698

2,041

2,904

2,901

2,861

2,766

3,145

2,535

2,521

Total Current Liabilities

7

8

6

13

14

26

32

48

53

88

124

135

190

221

295

326

405

1,261

583

2,189

923

715

1,050

913

1,657

1,758

2,220

2,578

3,420

3,368

3,295

4,864

3,742

4,298

3,273

Long-Term Debt

4

5

- -

33

62

57

108

104

77

37

887

102

43

97

52

1,085

1,080

1,066

1,061

687

592

582

6,522

6,513

5,935

5,937

4,872

7,828

6,604

6,614

Deferred Revenue

- -

Deferred Tax Liabilities

- -

34

1,108

922

762

644

522

356

241

201

249

217

233

51

125

93

123

1,636

2,811

1,033

695

335

Other Non-Current Liabilities

- -

92

14

- -

14

50

55

72

80

332

308

254

326

400

604

659

650

906

723

1,629

1,389

1,349

1,330

1,321

- -

Total Non-Current Liabilities

4

5

- -

33

62

154

71

108

104

77

85

2,046

1,079

878

820

905

1,750

1,575

1,593

1,710

1,509

1,484

1,283

7,552

7,328

7,686

8,962

9,031

10,191

8,619

6,949

Other Liabilities

- -

0

- -

0

- -

Capital Lease Obligations

- -

413

402

330

333

Total Liabilities

11

12

13

6

13

14

26

32

48

86

150

278

206

298

325

372

412

2,451

2,339

1,461

1,403

3,095

2,673

2,290

2,643

2,623

3,166

3,242

3,503

10,130

10,748

11,055

12,257

13,895

13,933

12,918

10,222

Preferred Stock

- -

Common Stock

- -

0

1

2

0

Retained Earnings

(54)

(82)

(105)

(106)

(105)

(103)

(99)

(61)

(29)

(33)

(28)

13

25

214

352

544

706

839

(612)

(801)

(1,022)

(861)

(352)

270

1,069

1,872

3,107

4,487

6,349

9,284

12,208

15,072

15,810

16,257

16,455

13,976

13,912

16,959

Other Compreh. Income(Loss)

(13)

(19)

(9)

(11)

(13)

(15)

(19)

(21)

(26)

- -

16

1

(7)

(14)

22

79

(11)

50

(22)

(27)

(55)

(28)

(59)

(224)

(320)

(318)

(240)

(135)

(299)

(107)

(165)

Other Total Stockhold. Equity

142

190

181

185

257

264

357

367

379

363

410

471

510

504

626

561

641

739

7,664

7,634

7,941

7,989

5,807

5,547

5,102

3,546

3,345

2,530

2,299

1,584

(2,612)

(2,879)

(2,977)

(2,909)

- -

Total Stockholders Equity

75

89

68

139

146

239

285

325

330

383

484

536

719

980

1,106

1,349

1,595

7,053

6,826

6,906

7,150

5,534

5,806

6,222

5,397

6,425

6,962

8,620

10,809

9,373

12,140

12,613

13,040

13,343

10,700

10,896

13,398

Total Liab.&Stockhold. Equity

86

101

81

145

159

253

311

357

378

469

635

814

925

1,278

1,432

1,721

2,007

9,504

9,166

8,367

8,553

8,629

8,479

8,512

8,040

9,048

10,128

11,863

14,312

19,503

22,888

23,667

25,297

27,238

24,633

23,814

23,619

Minority Interest

- -

Total Liabilities & Equity

86

101

81

145

159

253

311

357

378

469

635

814

925

1,278

1,432

1,721

2,007

9,504

9,166

8,367

8,553

8,629

8,479

8,512

8,040

9,048

10,128

11,863

14,312

19,503

22,888

23,667

25,297

27,238

24,633

23,814

23,619

SEC Link

Link

Cash Flow Statement

Net Income

- -

3

8

7

38

32

(5)

6

41

89

139

220

334

273

199

- -

977

899

1,267

1,380

1,862

2,942

3,593

3,696

2,670

4,474

5,889

4,061

1,728

2,962

Depreciation and Amortization

- -

(3)

(4)

(5)

(7)

8

11

15

19

25

31

39

37

45

61

439

402

376

380

462

428

354

359

366

532

688

600

683

1,081

1,017

681

457

488

518

Deferred Income Tax

- -

(6)

22

7

(24)

25

(18)

42

(4)

9

(90)

(106)

(82)

(140)

(137)

(81)

154

(117)

(245)

(308)

(146)

(175)

92

108

67

149

(427)

(169)

Stock Based Compensation

- -

2

- -

17

38

127

123

146

161

168

113

119

136

155

161

155

128

158

182

198

239

254

Change in Working Capital

- -

(7)

(2)

(5)

(8)

7

28

(5)

(4)

(36)

(2)

24

(11)

(6)

(53)

(81)

(176)

100

(97)

(78)

176

(351)

4

(185)

104

87

(484)

(576)

73

235

400

199

(187)

(146)

1,384

Accounts Receivable

- -

(4)

(7)

(5)

(15)

2

- -

12

23

(77)

6

(37)

(71)

(58)

- -

(99)

(73)

4

(127)

(512)

29

(241)

(436)

(205)

69

3

325

(203)

Inventory

- -

(50)

(9)

(91)

(33)

(37)

(83)

(54)

(43)

(5)

(59)

(140)

(244)

(186)

(174)

(166)

(95)

(52)

(19)

(316)

(462)

336

Accounts Payable

- -

(2)

7

2

10

6

- -

Other Working Capital

- -

(1)

- -

8

(23)

56

(48)

(50)

(27)

(40)

(59)

39

(9)

42

180

(918)

5

(79)

34

334

64

94

(233)

1,304

322

16

(205)

86

- -

Other Non-Cash Items

- -

9

20

15

3

(2)

1

3

(1)

20

(21)

31

243

439

440

541

677

919

(2)

282

20

29

(28)

(50)

82

91

345

31

61

(448)

1,758

(3,566)

Cash Provided by Operating Activities

- -

(8)

11

6

43

48

35

9

47

98

168

272

366

316

267

219

728

890

841

1,021

1,564

1,075

1,625

1,728

1,880

2,345

2,942

3,716

4,522

4,551

6,188

7,079

4,230

3,640

1,384

CAPEX

- -

(3)

(11)

(8)

(9)

(11)

(44)

(50)

(66)

(36)

(34)

(86)

(199)

(196)

(222)

(301)

(370)

(318)

(198)

(284)

(276)

(166)

(173)

(252)

(261)

(3,509)

(288)

(643)

(728)

(1,963)

(886)

(670)

(552)

(295)

240

Acquisitions Net

- -

(6)

137

- -

(303)

(96)

(25)

- -

(157)

(5)

(72)

(15)

(375)

(1,049)

(1,200)

(2,177)

(121)

(566)

28

990

Purchases of Investments

- -

(52)

(15)

(37)

(12)

(53)

(27)

(349)

(370)

(482)

(574)

(1,120)

(627)

(828)

(467)

(1,233)

(3,213)

(1,454)

(1,959)

(2,969)

(3,184)

(3,592)

(1,993)

(3,713)

(3,334)

(3,278)

(3,583)

(6,865)

(7,913)

(5,355)

(8,158)

(5,253)

(6,839)

(3,809)

(3,449)

Sales/Maturities of Investments

- -

307

370

373

454

1,006

726

770

405

1,119

3,200

1,782

1,787

3,254

2,941

3,333

2,669

2,318

2,760

5,190

2,719

4,063

7,379

5,566

9,174

6,486

7,374

3,499

3,671

Other Investing Activities

- -

4

(3)

(2)

(20)

(18)

(10)

(14)

(10)

(5)

(1)

- -

(9)

408

74

(192)

178

30

- -

(42)

(49)

(3,255)

(16)

(60)

(134)

(1,106)

(115)

(128)

(154)

(24)

124

Cash Used for Investing Activities

- -

(51)

(30)

(48)

(24)

(67)

(70)

(92)

(82)

(155)

(159)

(210)

(105)

(253)

(290)

(279)

(382)

418

(600)

(287)

(366)

(395)

345

(1,650)

(950)

(1,605)

(1,543)

(4,554)

(2,485)

(2,963)

(2,046)

471

(609)

(564)

1,577

Debt Repayment

- -

(1)

(2)

(4)

(30)

(5)

- -

(746)

- -

(19)

(1,512)

(11)

(18)

(11)

(2)

(452)

(3)

(2)

(3)

(561)

(3)

- -

(1,500)

(170)

(1,002)

Common Stock Issued

- -

16

- -

20

24

41

172

36

35

27

24

274

120

147

489

178

48

183

315

- -

Common Stock Repurchased

- -

(7)

(66)

(198)

(300)

(88)

(8)

- -

(734)

(323)

(320)

(2,991)

(739)

(751)

(2,078)

(498)

(985)

(400)

(887)

(5,000)

(1,000)

(1,365)

(4,353)

(5,868)

(6,679)

(1,800)

(750)

Dividends Paid

- -

(3)

(6)

(3)

- -

Other Financing Activities

- -

67

4

89

10

8

- -

75

33

53

- -

0

- -

10

1

25

1,785

836

(10)

127

(125)

110

136

134

5,989

15

(454)

(116)

8

2,906

(116)

5

Cash Used/Provided by Financing Activities

- -

65

(2)

87

10

8

16

74

52

66

(54)

(31)

(269)

(58)

14

24

(451)

(949)

(148)

(735)

(1,237)

(724)

(1,785)

(320)

(877)

(717)

(756)

986

(988)

(2,380)

(4,472)

(5,860)

(5,273)

(2,086)

(1,747)

Effect of Forex Changes on Cash

- -

(0)

- -

(1)

- -

0

(1)

1

4

(7)

(3)

4

8

(41)

(46)

(31)

39

(19)

0

69

(60)

(56)

Net Change In Cash

- -

65

(2)

87

10

8

(20)

(9)

16

8

(45)

31

(8)

5

(9)

(35)

(105)

359

93

(2)

(37)

(40)

178

(245)

56

32

602

103

1,019

(753)

(349)

1,689

(1,583)

930

1,214

Cash at the End of Period

- -

55

46

62

70

25

57

49

54

45

315

209

568

661

660

622

582

760

515

571

603

1,205

1,308

2,327

1,574

1,225

2,914

1,331

2,261

3,475

Cash at the Beginning of Period

- -

27

33

13

57

86

75

55

46

62

70

25

57

49

54

350

315

209

568

661

660

622

582

760

515

571

603

1,205

1,308

2,327

1,574

1,225

2,914

1,331

2,261

Free Cash Flow

- -

(11)

(0)

(3)

34

37

(9)

(41)

(19)

62

134

186

167

121

46

(82)

358

571

643

737

1,289

909

1,452

1,476

1,619

(1,164)

2,654

3,073

3,795

2,588

5,302

6,409

3,678

3,345

1,625

SEC Link

Link

Forex Rate

- -

Powered by AI

Biogen Inc.

298.66